Table 6
Assessing the Patient for Category A Agents (
Continued
)
Pathogen(incubation period)
Systemic symptoms
Central nervoussystem
Cardiorespiratory
Gastrointestinal
Skin and mucousmembranes
Miscellaneous
Gastrointestinal
anthrax
(1–7 days
although commonly3–7 days)
Nausea, vomiting,
anorexia, fever,abdominal pain,hematemesis,bloody diarrhea.
An eschar forms on the wall
of the intestine, usuallythe terminal ileum orcaecum. Untreated, deathin 2–5 days, (25–60%mortality). Rare patientssuccumb within hours.
Anthrax meningitis
5% of anthrax cases
involve meningitisor hemorrhagicmeningoencephalitis.CT and MRI revealfocal intracerebralhemorrhage withleptomeningealenhancement.
25% of cases
develop frominhalationanthrax.
The majority of
anthrax meningitiscases developedfrom cutaneousdisease.
No primary focus
can be foundin 10% of cases.
An anthrax bioterrorist attack may result in all five forms of anthrax in a single patient or any permutation or combination of disease presenting in patients appearing
simultaneously or sequentially to a single institution or area institutions!
Botulism
(C. botulinum toxin
)
C. botulinum
,
C.
barattii
,C.
butyricum
,
C.
argentinense
toxins
A–G. (12–80 hr byinhalation;immediate to 12–72hr—range 2–8 daysby ingestion). Mostnaturally occurringhuman disease iscaused by types A,B, and E (Eassociated with fish;type C and D oftencause disease inmammals andbirds).
Patients are afebrile
and fatigue iscommon (77%).Typically causescranial nerveparalysis [facialparalysis (63%);gaze paralysis(65%); tongueweakness (58%);decreased gag(65%)] withoutaffection sensation.
Double vision (91%);
blurred vision (65%);pupils fixed anddilated pupils (40%);nystagmus (22%);ptosis (73%); slurredspeech, dizziness(51%); weakness(69–73%); unsteadygait, descendingweakness, flaccidparalysis with fullconsciousness(90%) untilrespiratory failure;paresthesias (14%);ataxia (17%).
Dyspnea (60%);
sensation of asore throat (54%).
Dysphagia (96%);
constipation (73%);nausea (64%);vomiting 59%;abdominal cramps(42%); diarrhea(19%).
Increased mucous
production in mouthand throat and/ordry mouth (93%)and throat.
444 Cleri et al.